Psychedelic Pharmaceutical Biotech Company Granted U.S. Patent Approval for Binge Behavior Treatment

Clearmind Medicine Inc., a clinical-stage biotech company, has received a new patent approval from the United States Patent and Trademark Office. This patent is a pivotal element of Clearmind's ongoing efforts to address binge behaviors, particularly in relation to alcohol consumption, through innovative treatments. $Clearmind Medicine (CMND.US)$